Market Research Logo

Pure Bioscience Inc (PURE) - Financial and Strategic SWOT Analysis Review

Pure Bioscience Inc (PURE) - Financial and Strategic SWOT Analysis Review

-provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Pure Bioscience Inc (Pure) is involved in the development and commercialization of proprietary antimicrobial products. It develops and markets proprietary antimicrobial products principally in the food safety field providing solutions to the health and environmental challenges of pathogen and hygienic control. The company’s technology platform is based on patented stabilized ionic silver, and its initial products contain silver dihydrogen citrate (SDC), a broad-spectrum, non-toxic antimicrobial agent that provides 24-hour residual protection and formulates well with other compounds. It also manufactures and sells SDC-based formulations to manufacturers for use as a raw material ingredient in the production of personal care products. Pure is headquartered in El Cajon, California, the US.

Pure Bioscience Inc Key Recent Developments

Nov 02,2017: PURE Bioscience Expands Board of Directors with Appointment of Elisabeth Hagen, M.D., Food Safety Consultant
Jun 08,2017: PURE Bioscience reports 2017 fiscal Q3 and nine-month financial results
Apr 27,2017: PURE Bioscience Receives USDA Permission Letter and FDA FCN Acknowledgement Letter
Mar 02,2017: PURE Bioscience Reports Improved 2017 Fiscal Second Quarter and Six-Month Financial Results
Dec 14,2016: PURE Bioscience Reports Q1 2017 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Pure Bioscience Inc - Key Facts
Pure Bioscience Inc - Key Employees
Pure Bioscience Inc - Key Employee Biographies
Pure Bioscience Inc - Major Products and Services
Pure Bioscience Inc - History
Pure Bioscience Inc - Company Statement
Pure Bioscience Inc - Locations And Subsidiaries
Head Office
Section 2 – Company Analysis
Pure Bioscience Inc - Business Description
Pure Bioscience Inc - Corporate Strategy
Pure Bioscience Inc - SWOT Analysis
SWOT Analysis - Overview
Pure Bioscience Inc - Strengths
Pure Bioscience Inc - Weaknesses
Pure Bioscience Inc - Opportunities
Pure Bioscience Inc - Threats
Pure Bioscience Inc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Pure Bioscience Inc, Recent Deals Summary
Section 4 – Company’s Recent Developments
Nov 02, 2017: PURE Bioscience Expands Board of Directors with Appointment of Elisabeth Hagen, M.D., Food Safety Consultant
Jun 08, 2017: PURE Bioscience reports 2017 fiscal Q3 and nine-month financial results
Apr 27, 2017: PURE Bioscience Receives USDA Permission Letter and FDA FCN Acknowledgement Letter
Mar 02, 2017: PURE Bioscience Reports Improved 2017 Fiscal Second Quarter and Six-Month Financial Results
Dec 14, 2016: PURE Bioscience Reports Q1 2017 Financial Results
Oct 27, 2016: PURE Bioscience Reports Fiscal 2016 Year-End Financial Results
Jun 09, 2016: PURE Bioscience Reports 2016 Fiscal Third Quarter and Nine-Month Financial Results
Apr 07, 2016: PURE Bioscience Receives USDA Permission Letter to Begin In-Plant Poultry Processing Trial Using SDC-Based PURE Control Antimicrobial
Mar 09, 2016: PURE Bioscience Reports 2016 Fiscal Second Quarter and Six-Month Financial Results
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Pure Bioscience Inc, Key Facts
Pure Bioscience Inc, Key Employees
Pure Bioscience Inc, Key Employee Biographies
Pure Bioscience Inc, Major Products and Services
Pure Bioscience Inc, History
Pure Bioscience Inc, Key Competitors
Pure Bioscience Inc, Ratios based on current share price
Pure Bioscience Inc, Annual Ratios
Pure Bioscience Inc, Annual Ratios (Cont...1)
Pure Bioscience Inc, Interim Ratios
Pure Bioscience Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Pure Bioscience Inc, Performance Chart (2013 - 2017)
Pure Bioscience Inc, Ratio Charts

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report